Andere Sprachen Hyperfine, Inc.

Aktien

A3DBAC

US44916K1060

HYPR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 03.05.2024			% 5 Tage	% 1. Jan.
0,8 ^USD	+0,90 %		-5,33 %	-28,57 %

17.04.	Hyperfine, Inc. nimmt die ersten Alzheimer-Patienten, die eine Amyloid-gerichtete Therapie erhalten, in die Care PMR-Studie auf	CI
22.03.	HYPERFINE, INC. : Wells Fargo Securities gibt eine neutrale Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024	29.04.
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop System Images across Multiple Care Settings and Clinical Conditions	24.04.
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions	23.04.
Hyperfine, Inc. - Leading Institutions Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study	18.04.
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study	17.04.
Hyperfine, Inc. Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in Care PMR Study	17.04.
Earnings Flash (HYPR) HYPERFINE Posts Q4 Revenue $2.7M	21.03.
Hyperfine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.03.
Hyperfine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	21.03.
Hyperfine, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	21.03.
Hyperfine, Inc. Collaborates with King's College London to Demonstrate the Swoop System and UNITY Project to The Princess Royal	13.03.
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal	12.03.
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024	07.03.
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference	28.02.
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes	21.02.
Hyperfine, Inc. and Athletic Heart Cardiac and Metabolic Testing, Llc Announce Collaboration to Bring Portable Brain Imaging Screening to Current and Former Professional Athletes	21.02.
Hyperfine, Inc. Celebrates Breadth of Swoop System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study	02.02.
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study	01.02.
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use	09.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hyperfine, Inc.

Aktien

A3DBAC

US44916K1060

HYPR

Andere Sprachen

Filter